Glucosylceramidase Market, Global Outlook and Forecast 2022-2028

Glucosylceramidase Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281441 | No. of Pages: 79 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Glucosylceramidase in global, including the following market information:
Global Glucosylceramidase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glucosylceramidase Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Glucosylceramidase companies in 2021 (%)
The global Glucosylceramidase market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
AVRRD-02 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucosylceramidase include Amicus Therapeutics, Inc., Bioorganic Research and Services S.A., greenovation Biotech GmbH, JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc., Takeda and The International Biotechnology Center (IBC) Generium, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucosylceramidase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucosylceramidase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glucosylceramidase Market Segment Percentages, by Type, 2021 (%)
    AVRRD-02
    LTI-291
    NCGC-607
    Pcgin
    Others
Global Glucosylceramidase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glucosylceramidase Market Segment Percentages, by Application, 2021 (%)
    Genetic Disorders
    Gaucher Disease
    Parkinson's Disease
    Others
Global Glucosylceramidase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glucosylceramidase Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucosylceramidase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glucosylceramidase revenues share in global market, 2021 (%)
Key companies Glucosylceramidase sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Glucosylceramidase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Amicus Therapeutics, Inc.
    Bioorganic Research and Services S.A.
    greenovation Biotech GmbH
    JCR Pharmaceuticals Co., Ltd.
    Pharming Group N.V.
    Protalix BioTherapeutics, Inc.
    Takeda
    The International Biotechnology Center (IBC) Generium
1 Introduction to Research & Analysis Reports
    1.1 Glucosylceramidase Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Glucosylceramidase Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Glucosylceramidase Overall Market Size
    2.1 Global Glucosylceramidase Market Size: 2021 VS 2028
    2.2 Global Glucosylceramidase Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Glucosylceramidase Sales: 2017-2028
3 Company Landscape
    3.1 Top Glucosylceramidase Players in Global Market
    3.2 Top Global Glucosylceramidase Companies Ranked by Revenue
    3.3 Global Glucosylceramidase Revenue by Companies
    3.4 Global Glucosylceramidase Sales by Companies
    3.5 Global Glucosylceramidase Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Glucosylceramidase Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Glucosylceramidase Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Glucosylceramidase Players in Global Market
        3.8.1 List of Global Tier 1 Glucosylceramidase Companies
        3.8.2 List of Global Tier 2 and Tier 3 Glucosylceramidase Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Glucosylceramidase Market Size Markets, 2021 & 2028
        4.1.2 AVRRD-02
        4.1.3 LTI-291
        4.1.4 NCGC-607
        4.1.5 Pcgin
        4.1.6 Others
    4.2 By Type - Global Glucosylceramidase Revenue & Forecasts
        4.2.1 By Type - Global Glucosylceramidase Revenue, 2017-2022
        4.2.2 By Type - Global Glucosylceramidase Revenue, 2023-2028
        4.2.3 By Type - Global Glucosylceramidase Revenue Market Share, 2017-2028
    4.3 By Type - Global Glucosylceramidase Sales & Forecasts
        4.3.1 By Type - Global Glucosylceramidase Sales, 2017-2022
        4.3.2 By Type - Global Glucosylceramidase Sales, 2023-2028
        4.3.3 By Type - Global Glucosylceramidase Sales Market Share, 2017-2028
    4.4 By Type - Global Glucosylceramidase Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Glucosylceramidase Market Size, 2021 & 2028
        5.1.2 Genetic Disorders
        5.1.3 Gaucher Disease
        5.1.4 Parkinson's Disease
        5.1.5 Others
    5.2 By Application - Global Glucosylceramidase Revenue & Forecasts
        5.2.1 By Application - Global Glucosylceramidase Revenue, 2017-2022
        5.2.2 By Application - Global Glucosylceramidase Revenue, 2023-2028
        5.2.3 By Application - Global Glucosylceramidase Revenue Market Share, 2017-2028
    5.3 By Application - Global Glucosylceramidase Sales & Forecasts
        5.3.1 By Application - Global Glucosylceramidase Sales, 2017-2022
        5.3.2 By Application - Global Glucosylceramidase Sales, 2023-2028
        5.3.3 By Application - Global Glucosylceramidase Sales Market Share, 2017-2028
    5.4 By Application - Global Glucosylceramidase Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Glucosylceramidase Market Size, 2021 & 2028
    6.2 By Region - Global Glucosylceramidase Revenue & Forecasts
        6.2.1 By Region - Global Glucosylceramidase Revenue, 2017-2022
        6.2.2 By Region - Global Glucosylceramidase Revenue, 2023-2028
        6.2.3 By Region - Global Glucosylceramidase Revenue Market Share, 2017-2028
    6.3 By Region - Global Glucosylceramidase Sales & Forecasts
        6.3.1 By Region - Global Glucosylceramidase Sales, 2017-2022
        6.3.2 By Region - Global Glucosylceramidase Sales, 2023-2028
        6.3.3 By Region - Global Glucosylceramidase Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Glucosylceramidase Revenue, 2017-2028
        6.4.2 By Country - North America Glucosylceramidase Sales, 2017-2028
        6.4.3 US Glucosylceramidase Market Size, 2017-2028
        6.4.4 Canada Glucosylceramidase Market Size, 2017-2028
        6.4.5 Mexico Glucosylceramidase Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Glucosylceramidase Revenue, 2017-2028
        6.5.2 By Country - Europe Glucosylceramidase Sales, 2017-2028
        6.5.3 Germany Glucosylceramidase Market Size, 2017-2028
        6.5.4 France Glucosylceramidase Market Size, 2017-2028
        6.5.5 U.K. Glucosylceramidase Market Size, 2017-2028
        6.5.6 Italy Glucosylceramidase Market Size, 2017-2028
        6.5.7 Russia Glucosylceramidase Market Size, 2017-2028
        6.5.8 Nordic Countries Glucosylceramidase Market Size, 2017-2028
        6.5.9 Benelux Glucosylceramidase Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Glucosylceramidase Revenue, 2017-2028
        6.6.2 By Region - Asia Glucosylceramidase Sales, 2017-2028
        6.6.3 China Glucosylceramidase Market Size, 2017-2028
        6.6.4 Japan Glucosylceramidase Market Size, 2017-2028
        6.6.5 South Korea Glucosylceramidase Market Size, 2017-2028
        6.6.6 Southeast Asia Glucosylceramidase Market Size, 2017-2028
        6.6.7 India Glucosylceramidase Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Glucosylceramidase Revenue, 2017-2028
        6.7.2 By Country - South America Glucosylceramidase Sales, 2017-2028
        6.7.3 Brazil Glucosylceramidase Market Size, 2017-2028
        6.7.4 Argentina Glucosylceramidase Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Glucosylceramidase Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Glucosylceramidase Sales, 2017-2028
        6.8.3 Turkey Glucosylceramidase Market Size, 2017-2028
        6.8.4 Israel Glucosylceramidase Market Size, 2017-2028
        6.8.5 Saudi Arabia Glucosylceramidase Market Size, 2017-2028
        6.8.6 UAE Glucosylceramidase Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Amicus Therapeutics, Inc.
        7.1.1 Amicus Therapeutics, Inc. Corporate Summary
        7.1.2 Amicus Therapeutics, Inc. Business Overview
        7.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Major Product Offerings
        7.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.1.5 Amicus Therapeutics, Inc. Key News
    7.2 Bioorganic Research and Services S.A.
        7.2.1 Bioorganic Research and Services S.A. Corporate Summary
        7.2.2 Bioorganic Research and Services S.A. Business Overview
        7.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Major Product Offerings
        7.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.2.5 Bioorganic Research and Services S.A. Key News
    7.3 greenovation Biotech GmbH
        7.3.1 greenovation Biotech GmbH Corporate Summary
        7.3.2 greenovation Biotech GmbH Business Overview
        7.3.3 greenovation Biotech GmbH Glucosylceramidase Major Product Offerings
        7.3.4 greenovation Biotech GmbH Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.3.5 greenovation Biotech GmbH Key News
    7.4 JCR Pharmaceuticals Co., Ltd.
        7.4.1 JCR Pharmaceuticals Co., Ltd. Corporate Summary
        7.4.2 JCR Pharmaceuticals Co., Ltd. Business Overview
        7.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Major Product Offerings
        7.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.4.5 JCR Pharmaceuticals Co., Ltd. Key News
    7.5 Pharming Group N.V.
        7.5.1 Pharming Group N.V. Corporate Summary
        7.5.2 Pharming Group N.V. Business Overview
        7.5.3 Pharming Group N.V. Glucosylceramidase Major Product Offerings
        7.5.4 Pharming Group N.V. Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.5.5 Pharming Group N.V. Key News
    7.6 Protalix BioTherapeutics, Inc.
        7.6.1 Protalix BioTherapeutics, Inc. Corporate Summary
        7.6.2 Protalix BioTherapeutics, Inc. Business Overview
        7.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Major Product Offerings
        7.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.6.5 Protalix BioTherapeutics, Inc. Key News
    7.7 Takeda
        7.7.1 Takeda Corporate Summary
        7.7.2 Takeda Business Overview
        7.7.3 Takeda Glucosylceramidase Major Product Offerings
        7.7.4 Takeda Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.7.5 Takeda Key News
    7.8 The International Biotechnology Center (IBC) Generium
        7.8.1 The International Biotechnology Center (IBC) Generium Corporate Summary
        7.8.2 The International Biotechnology Center (IBC) Generium Business Overview
        7.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Major Product Offerings
        7.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales and Revenue in Global (2017-2022)
        7.8.5 The International Biotechnology Center (IBC) Generium Key News
8 Global Glucosylceramidase Production Capacity, Analysis
    8.1 Global Glucosylceramidase Production Capacity, 2017-2028
    8.2 Glucosylceramidase Production Capacity of Key Manufacturers in Global Market
    8.3 Global Glucosylceramidase Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Glucosylceramidase Supply Chain Analysis
    10.1 Glucosylceramidase Industry Value Chain
    10.2 Glucosylceramidase Upstream Market
    10.3 Glucosylceramidase Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Glucosylceramidase Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com